Sigma Healthcare Limited (ASX: SIG)
Australia
· Delayed Price · Currency is AUD 2.420
+0.100 (4.31%)
Nov 21, 2024, 4:10 PM AEST
Sigma Healthcare Cash Flow Statement
Financials in millions AUD. Fiscal year is February - January.
Millions AUD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 - 2015 |
| Net Income | -3 | 4.51 | 1.81 | -7.24 | 43.53 | -12.33 | Upgrade
|
| Depreciation & Amortization | 24.04 | 24.97 | 27.03 | 24.6 | 25.65 | 22.48 | Upgrade
|
| Other Amortization | 3.06 | 3.35 | 3.31 | 3.09 | 2.92 | 4.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | -10.71 | -10.71 | 6.49 | 1.65 | -29.26 | 1.14 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 6.99 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 1.3 | 0.5 | Upgrade
|
| Stock-Based Compensation | 2.75 | 2.75 | 1.93 | -0.01 | 0.86 | 1.69 | Upgrade
|
| Other Operating Activities | -96.16 | 0.8 | 1.27 | 7.76 | 6.28 | 2.99 | Upgrade
|
| Change in Accounts Receivable | 10.88 | 10.88 | 27.5 | -30.73 | -30.93 | 285.75 | Upgrade
|
| Change in Inventory | 103.72 | 103.72 | -3.21 | 27.5 | -33.65 | 27.78 | Upgrade
|
| Change in Accounts Payable | -102.65 | -102.65 | 53.54 | -7.11 | 5.14 | -133.18 | Upgrade
|
| Change in Income Taxes | 3.64 | 3.64 | -7.31 | -14.25 | -11.66 | -7.08 | Upgrade
|
| Change in Other Net Operating Assets | 0.69 | 0.69 | 16.64 | -51.52 | 6.69 | 8.24 | Upgrade
|
| Operating Cash Flow | -63.74 | 41.97 | 135.99 | -46.28 | -13.13 | 202.75 | Upgrade
|
| Operating Cash Flow Growth | - | -69.14% | - | - | - | 2293.78% | Upgrade
|
| Capital Expenditures | -5.69 | -4.72 | -29.4 | -14.21 | -51.44 | -57.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 8.37 | 8.93 | 0.05 | - | 182.13 | 4.77 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -8.92 | Upgrade
|
| Divestitures | - | - | 0.45 | - | - | - | Upgrade
|
| Investment in Securities | 1.53 | 1.53 | 0.3 | -2.39 | -6.33 | -7.15 | Upgrade
|
| Investing Cash Flow | 4.2 | 5.73 | -28.6 | -16.59 | 124.36 | -68.44 | Upgrade
|
| Long-Term Debt Issued | - | 725 | 385 | 165 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -814.5 | -480.13 | -16.38 | -264.56 | -77.21 | Upgrade
|
| Net Debt Issued (Repaid) | -86.19 | -89.5 | -95.13 | 148.62 | -264.56 | -77.21 | Upgrade
|
| Issuance of Common Stock | 395.59 | 396.12 | 0.88 | 0.2 | 0.49 | 5.28 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -0.05 | -0.05 | Upgrade
|
| Common Dividends Paid | -12.88 | -9.98 | -14.96 | -19.93 | - | -29.61 | Upgrade
|
| Other Financing Activities | -0.61 | -0.81 | -0.98 | - | -1.59 | -1.1 | Upgrade
|
| Financing Cash Flow | 295.91 | 295.83 | -110.19 | 128.89 | -265.71 | -102.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | 0 | 0.01 | 0 | -0.01 | 0 | Upgrade
|
| Net Cash Flow | 236.37 | 343.53 | -2.8 | 66.02 | -154.48 | 31.62 | Upgrade
|
| Free Cash Flow | -69.43 | 37.25 | 106.59 | -60.49 | -64.56 | 145.61 | Upgrade
|
| Free Cash Flow Growth | - | -65.05% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -1.99% | 1.12% | 2.91% | -1.76% | -1.90% | 4.49% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | 0.04 | 0.11 | -0.06 | -0.06 | 0.15 | Upgrade
|
| Cash Interest Paid | 17.05 | 16.95 | 13.14 | 4.11 | 7.67 | 11.5 | Upgrade
|
| Cash Income Tax Paid | - | -0.33 | 9.74 | 12.28 | -4.81 | 2.78 | Upgrade
|
| Levered Free Cash Flow | 453.7 | 46.07 | 104.06 | -51.57 | -61.83 | 146.76 | Upgrade
|
| Unlevered Free Cash Flow | 461.94 | 56.26 | 113.07 | -44.8 | -54.44 | 155.17 | Upgrade
|
| Change in Net Working Capital | 46.39 | -10.27 | -93.78 | 60.75 | 39.1 | -184.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.